Difficulty: Medium
Average Score: 74%
Practice
When starting therapy with trastuzumab, which finding should the nurse instruct the client to report?
Correct answer
A
Rationale
In pharmacology, understanding the side effects and adverse reactions of medications is crucial for safe and effective patient care. When starting therapy with trastuzumab, a monoclonal antibody used to treat certain types of cancer, the nurse should instruct the client to report dyspnea immediately. Dyspnea can be a sign of a serious side effect called cardiomyopathy, which is a known risk associated with trastuzumab therapy. Cardiomyopathy can lead to potentially life-threatening complications if not addressed promptly.
The other options (B) Constipation, (C) Tinnitus, and (D) Dry mouth are less concerning side effects compared to dyspnea when starting trastuzumab therapy. Constipation is a common gastrointestinal side effect, tinnitus is not typically associated with trastuzumab, and dry mouth is a minor side effect that does not pose immediate serious risks to the client's health.
Educationally, this question highlights the importance of recognizing and prioritizing potential side effects of medications to ensure patient safety. Nurses need to be vigilant in educating clients about signs and symptoms that warrant immediate attention to prevent serious complications and promote positive treatment outcomes.
The other options (B) Constipation, (C) Tinnitus, and (D) Dry mouth are less concerning side effects compared to dyspnea when starting trastuzumab therapy. Constipation is a common gastrointestinal side effect, tinnitus is not typically associated with trastuzumab, and dry mouth is a minor side effect that does not pose immediate serious risks to the client's health.
Educationally, this question highlights the importance of recognizing and prioritizing potential side effects of medications to ensure patient safety. Nurses need to be vigilant in educating clients about signs and symptoms that warrant immediate attention to prevent serious complications and promote positive treatment outcomes.